China Claims Sinovac 98% Effective at Creating Antibodies – Not Stopping Coronavirus – in Children
China’s state-run Global Times on Tuesday touted “Phase II clinical trial data” that suggests the Sinovac coronavirus vaccine is “at least 98.9 percent effective in producing antibodies” when administered to children from 3 to 17 years old. Unfortunately, China’s vaccines have a dubious record of actually preventing coronavirus infections.







































